Trypanosoma cruzi: Alteration in the lymphoid compartments following interruption of infection by early acute benznidazole therapy in mice

Experimental Parasitology

Volumn 114, Issue 3, 2006, Pages 228-234

  Olivieri, Bianca P ^a   de Souza, Andréa P ^a   Cotta de Almeida, Vinícius ^a   de Castro, Solange L ^a   Araújo Jorge, Tania ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Benznidazole; days post infection; Dpi; I; IBz; infected and benznidazole treated mice; infected and non treated mice; Lymphocytes; Lymphoid organs; Mice; N; NBz; non infected and benznidazole treated mice; non infected and non treated mice; Trypanosoma cruzi

Indexed keywords

BENZNIDAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; IMMUNE SYSTEM; LYMPH NODE; LYMPHATIC SYSTEM; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; LYMPHOID ORGAN; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTOZOAL INFECTION; SPLEEN; SPLENOMEGALY; T LYMPHOCYTE; THYMOCYTE; THYMUS; TRYPANOSOMA CRUZI;

ACUTE DISEASE; ANIMALS; B-LYMPHOCYTES; CHAGAS DISEASE; IMMUNITY, CELLULAR; LYMPH NODES; LYMPHOID TISSUE; MALE; MICE; NITROIMIDAZOLES; PARASITEMIA; SPLEEN; T-LYMPHOCYTES; THYMUS GLAND; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

TRYPANOSOMA CRUZI;

EID: 33749597333     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2006.02.020     Document Type: Article

References (39)

1. Andrade S.G., and Figueira R.M. Estudo experimental sobre a ação terapêutica da droga Ro 7-1051 na infecção por diferentes cepas do Trypanosoma cruzi. Revista do Instituto de Medicina Tropical de São Paulo 19 (1977) 335-341
2. Andrade S.G., Freitas L.A.R., Peyrol S., Pimentel A.R., and Sardigursky M. Trypanosoma cruzi antigens detected by immunoelectron microscopy in the spleen of mice serologically positive but parasitologically cured by chemotherapy. Revista da Sociedade Brasileira de Medicina Tropical 21 (1988) 41-42
3. Araújo-Jorge T.C., Sampaio E.P., De Souza W., and Meirelles M.N. Trypanosoma cruzi: the effect of variations in experimental conditions on the levels of macrophage infection in vitro. Parasitology Research 75 (1989) 257-263
4. Ben Younes-Chennouffi A., Hontebeyrie-Joskowicz M., Tricottet V., Eisen H., Reynes M., and Said G. Persistence of Trypanosoma cruzi antigens in inflammatory lesions of chronically infected mice. Transactions of the Royal Society of Tropical Medicine and Hygiene 82 (1988) 77-83
5. Bottasso O.A., Revelli S.S., Davila H., Valenti J.L., Musso O.C., Ferro M.E., Romero- Piffiguer M., and Morini J.C. Enhanced myocardial lesions in chronically Trypanosoma cruzi-infected rats subjected to adult thymectomy. Immunology Letters 37 (1993) 175-180
6. Brener Z. Present status of chemotherapy and chemoprophylaxis in human trypanosomiasis in the Western Hemisphere. Pharmacological Therapy 7 (1979) 71-90
7. Brener Z. Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Revista do Instituto de Medicina Tropical de São Paulo 4 (1962) 386-396
8. Cançado J.R., and Brener Z. Terapêutica. In: Brener Z., and Andrade Z. (Eds). Trypanosoma cruzi e Doença de Chagas (1979), Guanabara Koogan, Rio de Janeiro 362-424
9. Cotta-de-Almeida V., Bertho A.L., Villa-Verde D.M.S., and Savino W. Phenotypic and functional alterations of thymic nurse cells following acute Trypanosoma cruzi infection. Clinical Immunology and Immunopathology 82 (1997) 125-132
10. Cotta-de-Almeida V., Bonomo A., Mendes-da-Cruz D.A., Riederer I., De Meis J., Lima-Quaresma K.R., Vieira-de-Abreu A., Villa-Verde D.M., and Savino W. Trypanosoma cruzi infection modulates intrathymic contents of extracellular matrix ligands and receptors and alters thymocyte migration. European Journal of Immunology 33 (2003) 2439-2448
11. Coura J.R., and de Castro S.L. A critical review on Chagas disease chemotherapy. Memórias do Instituto Oswaldo Cruz 97 (2002) 3-24
12. D'Imperio Lima M.R., Eisen H., Minoprio P., Joskowicz M., and Coutinho A. Persistence of polyclonal B cell activation with undetectable parasitemia in late stages of experimental Chagas' disease. Journal of Immunology 137 (1986) 353-356
13. De Souza A.P., Olivieri B.P., De Castro S.L., and Araújo-Jorge T.C. Enzymatic markers of heart lesion in mice infected with Trypanosoma cruzi and submitted to benznidazole chemotherapy. Parasitology Research 86 (2000) 800-808
14. Dias J.C.P., and Coura J.R. Epidemiologia. In: Dias J.C.P., and Coura J.R. (Eds). Cli{dotless}́nica e terapêutica da doença de Chagas,uma abordagem prática para o cli{dotless}́nico geral (1997), FIOCRUZ, Rio de Janeiro 35-65
15. Galvão L., Nunes R., Cançado J.R., Brener Z., and Krettli A. Lytic antibodies titer as a means of assessing cure after treatment of Chagas' disease: a 10 year follow-up study. Transactions of the Royal Society of Tropical Medicine and Hygiene 87 (1993) 220-223
16. Kierszenbaum F., and Pienkowski M.M. Thymus-dependent control of host defense mechanisms against Trypanosoma cruzi infection. Infection and Immunity 24 (1979) 117-120
17. Kierszenbaum F. What are T-cell subpopulations really doing in Chagas' disease?. Parasitology Today 11 (1995) 6-7
18. Leite-de-Moraes M.C., Hontebeyrie-Joskowicz M., Leboulenger F., Savino W., Dardenne M., and Lepault F. Studies on the thymus in Chagas' disease. II. Thymocyte subset fluctuations in Trypanosoma cruzi-infected mice: relationship to stress. Scandinavian Journal of Immunology 33 (1991) 267-275
19. Luquetti, A.O., 1996. Etiological treatment for Chagas' disease. The National Health Foundation of Brazil. Technical Report, Brasi{dotless}́lia.
20. Michailowsky V., Murta S.M.F., Carvalho-Oliveira L., Pereira M.E., Ferreira L.R., Brener Z., Romanha A.J., and Gazzinelli R.T. Interleukin-12 enhances in vivo parasiticidal effect of benznidazole during acute experimental infection with a naturally drug-resistant strain of Trypanosoma cruzi. Antimicrobial Agents and Chemotherapy 42 (1998) 2549-2556
21. Minoprio P., Burlen O., Pereira P., Guilbert B., Andrade L., Hontebeyrie-Joskowicz M., and Coutinho A. Most B cells in acute Trypanosoma cruzi infection lack parasite specificity. Scandinavian Journal of Immunology 28 (1988) 553-561
22. Minoprio P., Coutinho A., Joskowicz M., D'Imperio-Lima M.R., and Eisen H. Polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. II. Cytotoxic T lymphocytes. Scandinavian Journal of Immunology 24 (1986) 669-679
23. Minoprio P., Eisen H., Forni L., D'Imperio-Lima M.R., Joskowicz M., and Coutinho A. Polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. I. Quantitation of both T- and B-cell responses. Scandinavian Journal of Immunology 24 (1986) 661-668
24. Minoprio P., Itohara S., Heusser C., Tonegawa S., and Coutinho A. Immunobiology of murine Trypanosoma cruzi infection: the predominance of parasite-non specific responses and the activation of TCRI T cells. Immunology Reviews 112 (1989) 183-207
25. Moncayo A. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Memórias do Instituto Oswaldo Cruz 98 (2003) 577-591
26. + T cell expansion and promotes resistance to reinfection. Antimicrobial Agents and Chemotherapy 46 (2002) 3790-3796
27. + double-positive thymocytes. Antimicrobial Agents and Chemotherapy 49 (2005) 1981-1987
28. Piaggio E., Roggero E., Pitashny M., Wietzerbin J., Bottasso O.A., and Revelli S.S. Treatment with benznidazole and its immunomodulating effects on Trypanosoma cruzi-infected rats. Parasitology Research 87 (2001) 539-547
29. Roggero E., Perez A., Tamae-Kakazu M., Piazzon I., Nepomnaschy I., Wietzerbin J., Serra E., Revelli S., and Bottasso O. Differential susceptibility to acute Trypanosoma cruzi infection in BALB/c and C57BL/6 mice is not associated with distinct parasite load but cytokine abnormalities. Clinical and Experimental Immunology 128 (2002) 421-428
30. Romanha A.J., Alves R.O., Murta S.M., Silva J.S., Ropert C., and Gazzinelli R.T. Experimental chemotherapy against Trypanosoma cruzi infection: essential role of endogenous interferon-γ in mediating parasitologic cure. Journal of Infectious Diseases 186 (2002) 823-828
31. Rottenberg M.E., Bakhiet M., Olsson T., Kristensson K., Mak T., Wigzell H., and Orn A. Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei. Infection and Immunity 61 (1993) 5129-5133
32. Savino W., Leite-de-Moraes M.C., Hontebeyrie-Joskowicz M., Leboulenger F., and Dardenne M. Studies on the thymus in Chagas'disease. I. Changes in the thymic microenvironment in mice acutely infected with Trypanosoma cruzi. European Journal of Immunology 19 (1989) 1727-1733
33. Schmunis G.A., Cappa S.M.G., Traversa O.C., and Jaanovsky J.F. The effects of immuno-depression due to neonatal thymectomy on infections with Trypanosoma cruzi in mice. Transactions of the Royal Society of Tropical Medicine and Hygiene 65 (1971) 89-94
34. Segura M.A., Molina de Raspi E., and Basombrio M.A. Reversibility of muscle and heart lesions in chronic Trypanosoma cruzi infected mice after late trypanomicidal treatment. Memórias do Instituto Oswaldo Cruz 89 (1994) 213-216
35. Soares M.B.P., Pontes-de-Carvalho L., and Ribeiro-dos-Santos R. The pathogenesis of Chagas' disease: when autoimmune and parasite-specific immune response meet. Anais da Academia Brasileira de Ciências 73 (2001) 547-559
36. Tarleton R.L., Sun J., Zhang L., and Postan M. Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease. Infection and Immunity 62 (1994) 1820-1829
37. Tarleton R.L. The role of T cells in Trypanosoma cruzi infection. Parasitology Today 1 (1995) 7-9
38. Viotti R., Vigliano C., Armenti H., and Segura E. Treatment of chronic Chagas disease with benznidazole: clinical and serological evolution of patients with long-term follow-up. American Heart Journal 127 (1994) 151-162
39. WHO, 2002. Chagas disease. Tropical Disease Research, 18th Program Report,UNDP/WB/TDR, Geneve.